Mirabegron and Hepatitis aggravated - a phase IV clinical study of FDA data

Summary:

Hepatitis aggravated is reported as a side effect among people who take Mirabegron (mirabegron), especially for people who are male, 60+ old, have been taking the drug for 1 - 6 months also take Ramipril, and have Acute myeloid leukaemia.

The phase IV clinical study analyzes which people have Hepatitis aggravated when taking Mirabegron. It is created by eHealthMe based on reports of 5,378 people who have side effects when taking Mirabegron from the FDA, and is updated regularly.

What is Mirabegron?

Mirabegron has active ingredients of mirabegron. It is often used in urge incontinence. eHealthMe is studying from 5,414 Mirabegron users. Check the latest studies of Mirabegron.

What is Hepatitis aggravated?

Hepatitis aggravated is found to be associated with 1,146 drugs and 433 conditions by eHealthMe. Check the latest studies of Hepatitis aggravated.

On Jul, 13, 2026

5,378 people reported to have side effects when taking Mirabegron.
Among them, 11 people (0.2%) have Hepatitis aggravated.

Could Mirabegron cause Hepatitis aggravated?

Among these 11 people:

How long have people been on Mirabegron when they have Hepatitis aggravated? *

What is the gender of people who have Hepatitis aggravated when taking Mirabegron? *

female: 36.36 %
male: 63.64 %

What is the age of people who have Hepatitis aggravated when taking Mirabegron? *

What are other drugs people take besides Mirabegron? *

Ramipril: 6 people, 54.55%
Azacitidine: 4 people, 36.36%
Glucophage: 4 people, 36.36%
Bisacodyl: 4 people, 36.36%
Allopurinol: 4 people, 36.36%
Lyrica: 4 people, 36.36%
Desoximetasone: 3 people, 27.27%
Pseudoephedrine Hydrochloride: 2 people, 18.18%
Prednisone: 2 people, 18.18%
Folic Acid: 2 people, 18.18%

What are other side effects people have besides Hepatitis aggravated? *

Weakness: 6 people, 54.55%
Pain In Extremity: 6 people, 54.55%
Constipation: 5 people, 45.45%
Drug Hypersensitivity: 5 people, 45.45%
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 5 people, 45.45%
Rashes (redness): 5 people, 45.45%
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect): 5 people, 45.45%
Cholangitis (infection of the bile duct): 4 people, 36.36%
Diabetic Neuropathy (neuropathic disorders that are associated with diabetes mellitus): 4 people, 36.36%
Cough: 4 people, 36.36%

What are the existing conditions these people have? *

Neuralgia (pain in one or more nerves): 4 people, 36.36%
Insomnia (sleeplessness): 4 people, 36.36%
High Blood Pressure: 4 people, 36.36%
Diabetes: 4 people, 36.36%
Constipation: 4 people, 36.36%
Bladder Disorder: 4 people, 36.36%
Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 4 people, 36.36%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 18.18%
Urinary Incontinence (inability to control the flow of urine and involuntary urination): 1 person, 9.09%
Stress And Anxiety: 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Mirabegron and have Hepatitis aggravated?

- Check whether Hepatitis aggravated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Mirabegron:

Mirabegron (5,414 reports)

Browse all side effects of Mirabegron:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hepatitis aggravated:

Hepatitis aggravated (1,147 drugs)

Browse all the conditions that are associated with Hepatitis aggravated:

Hepatitis aggravated (433 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on mirabegron (the active ingredients of Mirabegron) and Mirabegron (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.